Search research articles
Contact Us
Filters
Showing results (201-210 of 261) with videos related to
Page
of 27
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2007
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth
Roberto Bianchi, Alessandra Gilardini, Virginia Rodriguez-Menendez, et al.
International Journal of Molecular Sciences
|
September 9, 2022
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
Elisa Ballarini, Alessio Malacrida, Virginia Rodriguez-Menendez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 20, 2017
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
Jordi Bruna, Sebastián Videla, Andreas A Argyriou, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 24, 2013
Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations
Kathleen A Griffith, Darren J Couture, Shijun Zhu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 24, 2014
Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP
Eduardo Nobile-Orazio, Dario Cocito, Stefano Jann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 20, 2021
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy
Maria Elena Pero, Cristina Meregalli, Xiaoyi Qu, et al.
Scientific Reports
|
August 20, 2024
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation
Irina Utkina-Sosunova, Alessia Chiorazzi, Mariangels de Planell-Saguer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine
Claudio Pisano, Graziella Pratesi, Diletta Laccabue, et al.
Journal of the Peripheral Nervous System : JPNS
|
October 22, 2024
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy
Antonio Giuliano Zippo, Virginia Rodriguez-Menendez, Eleonora Pozzi, et al.
The Lancet. Neurology
|
May 15, 2012
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial
Eduardo Nobile-Orazio, Dario Cocito, Stefano Jann, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 261) with videos related to
Sort By:
Page
of 27
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2007
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth
Roberto Bianchi, Alessandra Gilardini, Virginia Rodriguez-Menendez, et al.
International Journal of Molecular Sciences
|
September 9, 2022
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
Elisa Ballarini, Alessio Malacrida, Virginia Rodriguez-Menendez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 20, 2017
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
Jordi Bruna, Sebastián Videla, Andreas A Argyriou, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 24, 2013
Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations
Kathleen A Griffith, Darren J Couture, Shijun Zhu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 24, 2014
Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP
Eduardo Nobile-Orazio, Dario Cocito, Stefano Jann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 20, 2021
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy
Maria Elena Pero, Cristina Meregalli, Xiaoyi Qu, et al.
Scientific Reports
|
August 20, 2024
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation
Irina Utkina-Sosunova, Alessia Chiorazzi, Mariangels de Planell-Saguer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine
Claudio Pisano, Graziella Pratesi, Diletta Laccabue, et al.
Journal of the Peripheral Nervous System : JPNS
|
October 22, 2024
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy
Antonio Giuliano Zippo, Virginia Rodriguez-Menendez, Eleonora Pozzi, et al.
The Lancet. Neurology
|
May 15, 2012
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial
Eduardo Nobile-Orazio, Dario Cocito, Stefano Jann, et al.
Page
of 27